Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian CarcinomaKsenija Nesic, Clare L. Scott, Olga Kondrashova et al.|Cancer Research|2021Cited by 91
The Effect of <i>Undaria pinnatifida</i> Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast CancerShreya Tocaciu, J. Helen Fitton, Georgia McGuinness et al.|Integrative Cancer Therapies|2016Cited by 65
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistanceKsenija Nešić, Harold C. Sullivan, John J. Krais et al.|Molecular Cancer|2024Cited by 28